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OBJECTIVE: The aim of this study was to describe our early experience in the treatment of ruptured abdominal
aortic aneurysms with bifurcated endografts. We report on our initial twelve-month experience using this
approach.
METHODS: Clinical data on patients with ruptured abdominal aortic aneurysms treated at a single tertiary
center in Brazil were prospectively recorded. The eligibility for endovascular treatment was evaluated by
computed tomography scanning and anatomical features were determined based on the method of treatment.
RESULTS: From February 2012 to January 2013 (12 months), 28 consecutive patients (mean age 67.2 years, range
45-85 years) underwent treatment for ruptured abdominal aortic aneurysms at our hospital. Eighteen patients
(64.3%) were suitable for and underwent endovascular treatment with bifurcated endografts (16 patients) or
aortouniiliac endografts (two patients). Ten patients who were considered unsuitable for endograft repair
underwent open repair. Seven patients were classified as hemodynamically unstable (Endovascular, 5; Open, 2),
and 21 were classified as stable (Endovascular, 13; Open, 8). The overall 30-day mortality rate associated with
endovascular treatment was 27.8% (stable, 18.7%; unstable, 40%) and the rate associated with open repair was
50% (stable, 37.5%; unstable, 100%).
CONCLUSIONS: In this study, the suitability of patients for endovascular repair of ruptured abdominal aortic
aneurysms was high and the overall results of endovascular treatment remain encouraging. Indeed, bifurcated
endografts are a feasible option for treating anatomically eligible ruptured abdominal aortic aneurysms.
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& INTRODUCTION
The worldwide mortality rate for patients undergoing
conventional repair of ruptured abdominal aortic aneur-
ysms (RAAAs) is up to 50% (1). Despite advances in
critical care and surgical techniques, the results of
conventional repair have been relatively poor in the last
few decades (2). Since 1994, endovascular aneurysm repair
(EVAR) has been used to treat RAAAs. Initially, the
endovascular technique used for EVAR was aortouniiliac
(AUI) endografting with femorofemoral crossover (3,4).
Since its initial use, EVAR has been increasingly used to
treat RAAAs (REVAR), yielding encouraging results and a
possible improvement in the number of operative deaths,
although no results from completed randomized trials are
available to date (5).
Conventional repair may be challenging, it is associated
with the risk of injury to the vascular system and other
organs and requires general anesthesia in potentially
unstable patients. EVAR offers several potential advantages,
namely, it is less invasive, eliminates damage to periaortic
and abdominal structures, decreases bleeding from surgical
dissection and reduces the requirement for deep anesthesia
(6). However, EVAR has some limitations and is not feasible
in all cases. Eligibility for EVAR is mainly related to
anatomical factors such as infrarenal neck morphology
and iliac artery patency. Furthermore, optimal planning
for EVAR requires preoperative imaging tests, which
may delay the treatment. This approach requires both a
permanent vascular team that is well trained in endovas-
cular techniques and the availability of a wide variety of
endografts in the hospital.
Bifurcated endografting is the standard EVAR approach
in elective cases worldwide and has been increasingly used
in REVAR in many centers (6,7). Our group has extensive
experience with EVAR in elective cases and has been using
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EVAR for RAAAs for approximately five years. Almost
50 cases had been completed at the time this study
was initiated, most of which had been treated with AUI
endografts. The experience and skills acquired with EVAR
in elective cases have been useful in emergency cases.
Therefore, in February 2012, we decided to repair all the
anatomically eligible RAAAs with bifurcated endografts.
We report our initial 12-month experience using this
approach.
& METHODS
This was a nonrandomized, single-center study. Clinical
data were prospectively recorded and analyzed. A surgical
team consisting of two vascular surgery residents and a staff
vascular surgeon is permanently present in the emergency
department of our hospital and the chief resident and a
senior surgeon are permanently on call for aortic emergen-
cies. In addition, we have a wide variety of endovascular
materials for EVAR available in the surgical supply storage
room. These characteristics make it possible to offer full-
time endovascular service in our hospital.
All procedures were performed in the operating room,
and even the EVAR patients were prepared for open repair
if necessary. Fluoroscopic monitoring was performed with a
mobile C-arm (OEC 9900, GE Medical system, USA; or BV
Pulsera; Philips, USA).
The computed tomography (CT) room of the emergency
department is connected to the emergency room; therefore,
CT scans can be performed within approximately 15
minutes after admission in emergency situations, especially
when the patient is expected from another hospital after
prior phone contact. CT scans were performed in all patients
admitted without this exam, even in patients with a systolic
blood pressure less than 80 mmHg, i.e., unstable patients.
During CT scanning, the operating room was prepared to
further reduce delay. Patients with previously known or
suspected renal function impairment underwent a CT
scan without contrast enhancement. Each patient received
intravenous N-acetylcysteine and sodium bicarbonate to
reduce contrast-induced nephropathy (8).
Immediately after CT scanning, patients were individu-
ally evaluated to identify their suitability for endovascular
repair. Anatomical suitability was assessed in all patients
with aortic aneurysm rupture on CT. Unruptured sympto-
matic aneurysms were excluded from this study.
Patients were monitored by a member of the vascular
team from the time of arrival at the emergency department
until they entered the operating room. Fluid restriction was
applied in all patients, even in the hypotensive cases,
leading to permissive hypotension to keep systolic blood
pressure at approximately 80 mmHg and avoid bleeding
onset or increase (9).
Patients who were eligible for EVAR were positioned
supine on the angiographic table, and the right upper limb
was angled 90˚ to the body, providing venous access and an
arterial line for the anesthesiologists. The left arm was
positioned along the body to permit free movements of the
C-arm. A central venous line and a diuresis catheter were
also inserted. Short-term antibiotic prophylaxis was per-
formed with cefazolin.
Direct surgical exposure of the femoral arteries was
achieved by using short oblique groin incisions. This step
was performed under local anesthesia (lidocaine 0.5%) in
most patients (Fig. 1). A Superstiff Lunderquist guidewire
(Cook Inc., Bloomington, IN, USA) was introduced through
one side until the thoracic aorta was reached. A Pig Tail
catheter (Cook Inc., IN, USA) was introduced through the
other side until reaching the level of the renal arteries, as
previously identified on the CT scan. A compliant balloon
(Reliant; Medtronic, World Medical Manufacturing Corp.,
FL, USA) and an introducer sheath (12F, 45 cm; Flexor,
Cook, IN, USA) were placed over the Lunderquist guide-
wire in the suprarenal aorta to promote aortic occlusion in
case of severe circulatory collapse, as previously described
(10). When the chosen device, according to preoperative CT
results, was ready for insertion and deployment, general
anesthesia was initiated to eliminate patient movement,
which improves fluoroscopic imaging and enables precise
graft deployment. All patients underwent an intraoperative
completion angiography to confirm aneurysm exclusion.
Most of these patients did not receive systemic heparin
due to the increased risk of bleeding. Heparin was
preferably used locally in femoral arteries only at the end
of the procedure.
Fluid resuscitation was instituted after the surgeon
informed the anesthesiologists that the aneurysm had been
excluded from circulation, and blood pressure was cor-
rected to more physiological values. After the procedure,
the patients were transferred to the intensive care unit for
standard postoperative care.
& RESULTS
A total of 28 patients with RAAAs were consecutively
treated at our hospital from February 2012 to January 2013
(12 months). A total of 18 patients (64.3%) were considered
suitable for (based on their anatomy) and underwent EVAR.
In 2 of these 18 patients, EVAR was performed with AUI
grafts due to unilateral iliac occlusions.
The other 16 EVAR cases were treated with bifurcated
endografts. Contralateral gate cannulation and a complete
endovascular procedure were possible in all patients.
Furthermore, aneurysm exclusion, which was evaluated
on the angiogram and performed at the end of the
procedure, was achieved in 100% of cases in the endovas-
cular group. No patient required emergent conversion of
bifurcated stent grafts to AUI devices or open surgery.
Figure 1 - Image shows an awake patient being treated for a
ruptured aneurysm under local anesthesia.
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The remaining 10 patients (35.7%) were considered
unsuitable for endovascular repair and were treated with
the open repair approach (Table 1). Anatomical contra-
indications for EVAR in these cases were an unsuitable or
absent infrarenal neck in seven cases, bilateral iliac obstruc-
tion in two cases and a complex infrarenal aortic dissection
in one case.
CT scans were performed in 16 patients. The other 12
patients arrived at our emergency department with a
previous CT exam from other hospitals. No patient died
or exhibited a worse hemodynamic status during transpor-
tation or performance of the CT scan.
The patients’ mean age was 67.2 years (45-85 years), and
the mean aneurysm diameter was 77.7 mm (50-120 mm).
Seven patients (25.9%) were hemodynamically unstable, 5
(29.4%) in the endovascular group and 2 (20%) in the open
repair group. The mean length of the proximal neck was
18.8 mm (6-48 mm) in the endovascular group and 6.7 mm
(0-33 mm) in the open repair group. Four patients in the
REVAR group had a proximal neck that was shorter than
10 mm (6, 7, 7 and 8 mm).
Of the 28 patients, 10 (35.7%) had been previously
diagnosed with AAA prior to rupture, 4 had not previously
undergone surgery due to poor clinical conditions and high
risks related to the procedure, 3 had refused surgery and 3
were waiting for elective repair. No patient refused surgery
after the diagnosis of RAAA.
A supraceliac aortic occlusion balloon was successfully
used in two patients because of severe circulatory collapse
during REVAR with bifurcated endografts.
The devices used were Endurant (Medtronic, CA, USA) in
14 patients (77.8%), Zenith (Cook, IN, USA) in 1 patient
(5.5%), AFX (Endologix, CA, USA) in 2 patients (11.1%) and
Anaconda (Vascutek, Inchinnan, UK) in 1 patient (5.5%).
All REVAR procedures in unstable patients were initiated
under local anesthesia, which was combined with intrave-
nous sedation for pain relief and patient immobility when
necessary (Table 2). All procedures were completed under
general anesthesia. Intravenous heparin was not used in
unstable patients and it was used in 54% (7/13) of the stable
patients based on the surgeon’s discretion.
The 30-day mortality rate was 27.8% (5/18) in the
endovascular group, and 2 of these deaths occurred in
unstable patients. In the open repair group, the periopera-
tive mortality rate was 50% (5/10), and 2 of the deaths
occurred in unstable cases (Fig. 2). The overall mortality rate
was 35.7% (10/28), and the difference in this rate between
the OPEN and EVAR groups was not statistically significant
(p= 0.221). The median total hospital stay of the survivors in
the REVAR group was 9 days (3-26 days), whereas that in
the open repair group was 15.6 days (7-40 days; p= 0.208).
The following major complications occurred in 7 patients
in the REVAR group (38.8%): acute renal failure requiring
dialysis (n = 3); pneumonia (n = 2); myocardial infarction
(n = 3); intra-abdominal compartment syndrome (n = 2) in
two unstable patients in the endovascular group, one of
whom was treated with surgical evacuation immediately
after surgery and the other of whom underwent delayed
laparotomy and died due to multiple organ failure before
drainage; colon ischemia (n= 1); lower limb ischemia (n = 1);
and prolonged ileus (n = 1). Six patients (60%) in the open
repair group had the following major complications:
acalculous cholecystitis (n = 1), evisceration (n = 1), lower
limb ischemia (n= 1), myocardial infarction (n= 2) and acute
renal failure requiring dialysis (n = 1).
& DISCUSSION
In this study, we included only patients with evidence of
ruptured aneurysms and showed that approximately 64.2%
of patients admitted with RAAA were deemed suitable for
REVAR. Most patients who were deemed unfit had an
unsuitable infrarenal aortic neck (7/10). We did not intend
to compare open and endovascular repair because of the
absence of randomization and the heterogeneity of the
groups, especially considering the more complex anatomy
in the open repair group.
AUI endografts were adopted in the early phase of
REVAR worldwide due to its rapid deployment, which is
possible because there is no need to cannulate the
contralateral gate (3,4,11). This procedure has a shorter
learning curve, which makes it attractive to some groups
that are beginning to use REVAR. We believe that the
greatest advantage of AUI endografts may be achieved in
unstable patients because of the faster hemorrhage control
afforded by these grafts. However, this procedure requires
an occluder device in the contralateral common iliac artery
to achieve complete control of any intra-abdominal bleed-
ing, which could be time-consuming in an emergency
situation. This procedure also requires a femorofemoral
prosthetic bypass, carrying risks such as late occlusion or
infection.
Recent publications from experienced centers have
demonstrated a preference for bifurcated endografts with
encouraging results (7,12). Verhoeven et al. reported a short
mean total operating time with this approach in
Table 1 - Summary of all patients’ clinical and anatomical features.
EVAR Open Overall
Number of patients 18 10 28
Median age, y (range) 67.3 (45-81) 67.2 (46-85) 67.2 (45-85)
Gender (M/F) 16/2 9/1 25/3
Unstable 5 2 7 (25%)
Stable 13 8 21 (75%)
Maximum AAA diameter, mm (range) 74 (50-120) 84.2 (60-112) 77.7 (50-120)
Neck diameter, mm (range) 22.2 (19-25) 21.2 (19-26) 21.9 (19-25)
Neck length, mm (range) 18.8 (6-48) 6.7 (0-33) 14.5 (0-48)
30-day mortality 5 (27.8%) 5 (50%) 10 (35.7%)
Severe systemic complications 7 (38.8%) 6 (60%) 13 (46.4%)
Total hospital stay, d (range) 9 (3-26) 15.6 (7-40) 11.3 (3-40)
EVAR: endovascular repair, AAA: abdominal aortic aneurysm.
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acute situations (13), similar to that reported in some AUI
studies (14). Acquired experience and some techniques,
such as aortic balloon occlusion, have enabled the safe
use of bifurcated grafts in REVAR. Indeed, in the present
study, AUI endografts were used only if the anatomy
represented a contraindication for the use of the bifurcated
system.
Patients with ruptured aneurysms appear to have larger
aneurysm diameters and shorter proximal necks (15). With
increasing experience, there seems to be a common
tendency in endovascular centers to extend EVAR indica-
tions to more challenging cases. Consistent with other
authors, we performed REVAR in patients with proximal
necks that were shorter than 10 mm (7,16). When the
intention was to use bifurcated grafts, we successfully
cannulated the contralateral gate in all cases, with no
instances of conversion to AUI devices.
Performing a preoperative CT scan is one of the most
interesting issues regarding REVAR. It is an extremely
important imaging exam for surgical planning but may
cause a delay in unstable cases or in patients who are at risk
of instability. Hinchcliffe et al. reported that the concern that
CT scanning prior to surgery could be detrimental to
patients seems to be unfounded (5). Patients who were
considered unfit for CT scanning due to hemodynamic
instability had bad outcomes with open surgery. It seems
that early surgery does not confer a survival benefit, and,
conversely, a delay does not translate to increased mortality.
Lloyd et al. reported a survival time longer than 2 hours in
87.5% of untreated patients with ruptured aneurysms and a
median time between admission and death of more than 10
hours (17). In most cases, there is sufficient time available to
safely image the patients prior to endovascular repair (18).
As in other referral centers, in our emergency department,
Table 2 - Summary of endovascular cases.
Stable Unstable Overall
Number of patients 13 5 18
Product
Endurant 9 (7 BIF, 2 AUI) 5 14 (77.8%)
Zenith 1 - 1 (5.5%)
Endologix 2 - 2 (11.1%)
Anaconda 1 - 1 (5.5%)
Anesthesia
Local to general 6 (46%) 5 (100%) 11 (61%)
General 7 (54%) - 7 (39%)
Intravenous heparin 7 (54%) - 7 (39%)
30-day mortality 3 (18.7%) 2 (40%) 5 (27.8%)
Severe systemic complications 4 (30.7%) 3 (60%) 7 (38.8%)
Acute renal failure (dialysis) 1 2{{ 3
Pneumonia 1 1{ 2
Myocardial infarction 1* 2{1 3
Intra-abdominal compartment syndrome - 2{1 2
Colon ischemia - 1{ 1
Lower limb ischemia 1 - 1
Prolonged ileus 1* - 1
BIF: bifurcated endograft, AUI: aortouniiliac endograft. *, {, {, 1 represent the same patient.
Figure 2 - Survival rate (Kaplan-Meier) of patients who underwent REVAR or OPEN repair to treat a ruptured abdominal aortic
aneurysm.
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CT scanning can be promptly performed, with minimum
patient transportation (19). We decided to perform CT scans
in all patients admitted without this exam, even in those
with a systolic blood pressure less than 80 mmHg, i.e.,
unstable patients, because of the importance and speed of
this exam. Moreover, with regards to REVAR, the decision
about the feasibility of this approach can be made in real-
time during image processing. We believe that maintaining
permissive hypotension is a major factor associated with the
safe performance of this exam.
Hemodynamic instability during induction of general
anesthesia remains the most challenging issue associated
with RAAA. The use of local anesthesia and avoidance of a
loss of abdominal tone are important advantages of REVAR,
but it also carries some potential disadvantages, including
patient discomfort and movement artifacts that may cause
inaccurate deployment of the grafts. We addressed this
issue by using a hybrid approach. In the majority of our
patients, the femoral arteries were accessed, and the
guidewires and catheters were placed under local anesthe-
sia. Based on a previous CT scan, a selected endograft was
prepared, and a compliant balloon and a 12F introducer
sheath were always ready for use in case of hemodynamic
collapse. General anesthesia was then initiated. Although
some authors have reported using the occluding balloon in
up to 25% of cases, we only used it in two patients (11.1%).
We agree with other authors who believe that the main goal
is to achieve rapid deployment of the endograft and reserve
the occluding balloons for severely unstable patients (40-
50 mmHg systolic blood pressure) who are unable to
maintain their blood pressure without the balloon (20).
Hemodynamic instability has been the most widely used
criterion to define the severity of RAAA, although it is
difficult to designate a single parameter to define the
hemodynamic status because it depends on the amount and
rate of bleeding and the previous conditions of the patient.
Similar to other studies, we selected a blood pressure cutoff
of 80 mmHg (6,17,18) to define the hemodynamic status.
We obtained a survival rate of 66.6% (4/6) among the
unstable patients in the endovascular group and we
reinforce the importance of performing CT scans and
assessing REVAR suitability in these patients. Consistent
with other authors, we believe that this group of patients
could be the most likely to benefit from a less invasive
procedure (18,20).
Three patients in the REVAR group developed renal
failure requiring dialysis; one stable patient had previously
known severe renal function impairment and required
postoperative dialysis despite the completion of preopera-
tive CT scanning without contrast enhancement and with
restriction of the use of contrast during the procedure,
and two unstable patients developed renal failure due to
contributing factors such as intra-abdominal compartment
syndrome and postoperative myocardial infarction requir-
ing cardiac catheterization with the use of more iodinated
contrast (Table 2). Although the stable patient who required
dialysis had an aneurysm neck shorter than 10 mm, no
patient in this series experienced coverage of the renal
arteries with the endografts.
Although there are several studies on REVAR, most of
them used very different methods of patient selection and
included less than 30 patients, making it difficult to compare
them. The mortality rate among such studies ranges from
9.5-46% (5,7). We obtained a mortality rate of 27.7% (5/18)
in the REVAR group, which is comparable to that in other
specialized centers. Our overall mortality rate was 35.7%
(10/28), which is lower than the historical mortality
associated with the open approach (1,2,7). Indeed, we
believe that bifurcated endografts are a feasible option for
treating anatomically eligible ruptured aneurysms and may
represent a valuable approach in experienced centers.
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